A type of immune cell targeting the Epstein-Barr virus may play a key role in driving multiple sclerosis (MS), a study found.

Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK ...

Researchers have demonstrated how B cells infected with the Epstein-Barr virus (EBV) can contribute to a pathogenic, inflammatory phenotype that contributes to multiple sclerosis (MS); the group has ...

New clinical trial data suggest vidofludimus calcium can target key mechanisms underlying progressive multiple sclerosis.

New research shows early Multiple Sclerosis brain damage is dynamic and reversible. Myelin swellings can shrink and disappear ...

More than two decades ago, a research team in the lab of David Hafler, a Yale researcher who at the time was at Harvard, discovered a type of T cell in humans that suppresses the immune system; they ...

A biological, mechanism-based framework to reclassify multiple sclerosis (MS) types was proposed by the International Advisory Committee on Clinical Trials in Multiple Sclerosis. The approach lays the ...

Multiple sclerosis (MS) is a chronic autoimmune disease caused by the interaction between environmental factors, such as high dietary salt intake, and genetic risk factors. When regulatory T cells, ...

For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...